Beta-Blocking Agent for Treatment of Infantile Hemangioma

被引:48
作者
Bigorre, Michele [1 ]
Van Kien, Aurelie Khau [2 ]
Valette, Huguette [3 ]
机构
[1] Lapeyronie Hosp, Dept Orthoped & Plast Pediat Surg, CHU Montpellier, F-34295 Montpellier, France
[2] St Eloi Hosp, Dept Vasc Med, CHU Montpellier, Montpellier, France
[3] Arnaud de Villeuneuve Hosp, Dept Pediat, CHU Montpellier, Montpellier, France
关键词
THERAPY;
D O I
10.1097/PRS.0b013e3181a3f435
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:195E / 196E
页数:2
相关论文
共 4 条
[1]  
Boon L-M, 2006, Ann Chir Plast Esthet, V51, P310, DOI 10.1016/j.anplas.2006.07.004
[2]   Complications of systemic corticosteroid therapy for problematic hemangioma [J].
Boon, LM ;
MacDonald, DM ;
Mulliken, JB .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1999, 104 (06) :1616-1623
[3]   Vincristine treatment for function- and life-threatening infantile hemangioma [J].
Enjoras, O ;
Brevière, GM ;
Roger, G ;
Tovi, M ;
Pellegrino, B ;
Varotti, E ;
Soupre, V ;
Picard, A ;
Leverger, G .
ARCHIVES DE PEDIATRIE, 2004, 11 (02) :99-107
[4]   INTERFERON ALFA-2A THERAPY FOR LIFE-THREATENING HEMANGIOMAS OF INFANCY [J].
EZEKOWITZ, RAB ;
MULLIKEN, JB ;
FOLKMAN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (22) :1456-1463